Company news
Medicure Inc. news in 2016
Medicure Inc.'s news releases, calls and decks from 2016, newest first.
Medicure announces filing of ANDA in collaboration with Apicore
December 13, 2016
Medicure Closes Acquisition of Majority Interest in Apicore
December 1, 2016
Medicure to Hold Investor Call on November 21, 2016
November 18, 2016
Medicure Exercises Option to Acquire Majority Interest in Apicore
November 18, 2016
Medicure Reports Third Quarter 2016 Financial Results
November 9, 2016
Medicure to Announce Q3 2016 Financial Results on November 9, 2016
November 2, 2016
FDA Approves New AGGRASTAT® Product Format
September 1, 2016
Medicure Reports Second Quarter 2016 Financial Results
August 10, 2016
Medicure to Announce Q2 2016 Financial Results on August 10, 2016
August 3, 2016
Medicure Receives Response Letter from FDA on AGGRASTAT® sNDA for New Indication
July 7, 2016
Medicure Reports First Quarter 2016 Financial Results
May 11, 2016
Medicure Files Application for New AGGRASTAT® Product Format
May 11, 2016
Medicure Announces Departure of President and Chief Operating Officer
May 9, 2016
Medicure to Announce Q1 2016 Financial Results on May 11, 2016
May 4, 2016
Medicure Announces Grant of Options
April 7, 2016
Medicure Announces Upcoming Conference Presentations
April 5, 2016
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2015
March 30, 2016
Medicure To Announce Fiscal Year 2015 Financial Results on March 30, 2016
March 23, 2016
Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference
February 23, 2016
Medicure to present at Cantech Investment Conference
January 21, 2016
Medicure Announces Preliminary Revenue For Fiscal 2015
January 11, 2016
Medicure announces ANDA collaboration with Apicore
January 6, 2016
Decks in 2016
- Investor Presentation (March 2016)
Investor deck · 18 slides · Mar 31, 2016